IMNN
ImunonBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
IMNN vs peer average
84/100
IMNN vs. peer average (B vs. D)
Grade spread
B 1 · C 2 · D 2 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
HCWB is the first available peer comparator.
HCW Biologics is a reasonable micro-cap immunotherapy comparator for financing sensitivity, clinical-stage volatility, and long-dated execution risk, though it is not an ovarian-cancer indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMNN
Imunon
HCWB
HCW Biologics
Grade
B
F
Momentum
93
7
Value
41
41
Sentiment
53
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs HCWB
IMNN / HCWB
Grade Position
Above peers
IMNN vs. peer average (B vs. D)
84/100
Momentum
93
IMNNValue
41
IMNNSentiment
53
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMNN
HCWB is the first peer returned for this comparison set.

